Trials / Conditions / Clinical Pharmacology

Clinical Pharmacology

17 registered clinical trials studyying Clinical Pharmacology — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Study Evaluating the Effects of Itraconazole or Rifampin on the Pharmacokinetic Characteristics of Rocbrutin NCT07374224	Guangzhou Lupeng Pharmaceutical Company LTD.	Phase 1
Completed	The Mass Balance Study of LP-168 in Healthy Subjects NCT06126861	Guangzhou Lupeng Pharmaceutical Company LTD.	Phase 1
Completed	Effect of Coadministration of Itraconazole on the Pharmacokinetics of CRD-740 NCT05437094	Cardurion Pharmaceuticals, Inc.	Phase 1
Completed	Study to Compare the Effect of the Formulations (Orally Disintegrating Tablet and Film-coated Tablet) on Bioeq NCT04511611	Bayer	Phase 1
Completed	Study to Compare the Effect of the Formulations (Orally Disintegrating Tablet and Film-coated Tablet) on the B NCT04511637	Bayer	Phase 1
Completed	A Manufacturing Transfer Study Comparing the Bioequivalence of a Single Oral Dose of Claritin-D 12-Hour Extend NCT03517943	Bayer	Phase 1
Completed	A Manufacturing Transfer Study Comparing the Bioequivalence of a Single Oral Dose of Claritin-D 12-Hour Extend NCT03517930	Bayer	Phase 1
Completed	A Pharmacokinetic Trial of Naproxen Sodium and Diphenhydramine Hydrochloride Soft Capsules Versus Naproxen Sod NCT03424135	Bayer	Phase 1
Completed	Pharmacokinetic and Pharmacodynamics of B12019 and Neulasta® in Healthy Subjects NCT02629562	Cinfa Biotech	Phase 1
Completed	Bioequivalence Study of BAY 77-1931 Orally Disintegrating Tablet NCT03074058	Bayer	Phase 1
Completed	TAK-114 Single- and Multiple-Dose Phase 1 Study NCT02286518	Takeda	Phase 1
Completed	Effect of Food on the Pharmacokinetics of Single Oral Dose Administration of a Fixed-Dose Combination of SYR-3 NCT02276274	Takeda	Phase 3
Completed	A Phase I Clinical Pharmacology Study of TAK-233 in Healthy Subjects NCT02113020	Takeda	Phase 1
Completed	Single Dose Escalation Study to Investigate the Pharmacokinetics as Well as Safety and Tolerability of a Conco NCT03136666	Bayer	Phase 1
Completed	Study on the Safety of BAY 63-2521, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid NCT04366622	Bayer	Phase 1
Completed	Study to Investigate the Natriuretic Effects, Safety, Tolerability and Pharmacokinetics of BAY94-8862 NCT01473108	Bayer	Phase 1
Completed	Study on the Safety of BAY 63-2521, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid NCT04364464	Bayer	Phase 1